Vaxcyte Stock Options

PCVX Stock  USD 73.02  0.22  0.30%   
Vaxcyte's latest option contracts expiring on April 17th 2025 are carrying combined implied volatility of 1.26 with a put-to-call open interest ratio of 0.99 over 49 outstanding agreements suggesting . The total put volume is at 100.0, with calls trading at the volume of 131. This yields a 0.76 put-to-call volume ratio.

Open Interest Against April 17th 2025 Option Contracts

Vaxcyte option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Vaxcyte's lending market. For example, when Vaxcyte's puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Vaxcyte, he or she must hedge the risk by shorting Vaxcyte stock over its option's life.
The chart above shows Vaxcyte's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Vaxcyte's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Vaxcyte's option, there is no secondary market available for investors to trade.

Vaxcyte Maximum Pain Price Across 2025-04-17 Option Contracts

Max pain occurs when Vaxcyte's market makers reach a net positive position across all Vaxcyte's options at a strike price where option holders stand to lose the most money. By contrast, Vaxcyte's option sellers may reap the most after selling more options than buying, causing them to expire worthless.

In The Money vs. Out of Money Option Contracts on Vaxcyte

Analyzing Vaxcyte's in-the-money options over time can help investors to take a profitable long position in Vaxcyte regardless of its overall volatility. This is especially true when Vaxcyte's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Vaxcyte's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Vaxcyte's stock while costing only a fraction of its price.

Vaxcyte In The Money Call Balance

When Vaxcyte's strike price is surpassing the current stock price, the option contract against Vaxcyte stock is said to be in the money. When it comes to buying Vaxcyte's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Vaxcyte are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Vaxcyte Current Options Market Mood

Vaxcyte's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Vaxcyte Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Unfortunately, most Vaxcyte's options investors are not very successful. Vaxcyte's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current Vaxcyte contract

Base on the Rule 16, the options market is currently suggesting that Vaxcyte will have an average daily up or down price movement of about 0.0788% per day over the life of the 2025-04-17 option contract. With Vaxcyte trading at USD 73.02, that is roughly USD 0.0575. If you think that the market is fully incorporating Vaxcyte's daily price movement you should consider buying Vaxcyte options at the current volatility level of 1.26%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Purchasing Vaxcyte options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Vaxcyte calls. Remember, the seller must deliver Vaxcyte stock to the call owner when a call is exercised.

Vaxcyte Option Chain

When Vaxcyte's strike price is surpassing the current stock price, the option contract against Vaxcyte stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Vaxcyte's option chain is a display of a range of information that helps investors for ways to trade options on Vaxcyte. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Vaxcyte. It also shows strike prices and maturity days for a Vaxcyte against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
PCVX250417C001750006175.00.0 - 1.752.1Out
Call
PCVX250417C0017000034170.00.0 - 1.750.2Out
Call
PCVX250417C001650003165.00.0 - 1.750.95Out
Call
PCVX250417C001600001160.00.0 - 1.751.25Out
Call
PCVX250417C001550001155.00.0 - 1.651.65Out
Call
PCVX250417C001500004150.00.0 - 1.951.45Out
Call
PCVX250417C001450001145.00.0 - 2.750.85Out
Call
PCVX250417C001400001140.00.0 - 2.150.95Out
Call
PCVX250417C001350001135.00.0 - 2.051.2Out
Call
PCVX250417C001300001130.00.0 - 3.11.5Out
Call
PCVX250417C0012500035125.00.0 - 2.750.85Out
Call
PCVX250417C0012000097120.00.15 - 2.20.65Out
Call
PCVX250417C0011500017115.00.1 - 0.750.7Out
Call
PCVX250417C0011000038110.00.0 - 4.81.1Out
Call
PCVX250417C00105000275105.01.0 - 4.50.9Out
Call
PCVX250417C0010000025100.00.05 - 4.91.5Out
Call
PCVX250417C0009500050395.00.6 - 5.00.9Out
Call
PCVX250417C0009000047190.01.5 - 5.52.83Out
Call
PCVX250417C00085000885.02.55 - 6.53.4Out
Call
PCVX250417C0008000015280.04.4 - 8.54.6Out
Call
PCVX250417C000750002475.06.5 - 10.55.7Out
Call
PCVX250417C00070000270.09.0 - 13.411.4In
Call
PCVX250417C00060000260.016.0 - 19.914.0In
Call
PCVX250417C00040000140.032.4 - 37.070.6In
 Put
PCVX250417P001750000175.099.0 - 103.599.0In
 Put
PCVX250417P001700000170.094.0 - 98.594.0In
 Put
PCVX250417P001650000165.089.0 - 93.489.0In
 Put
PCVX250417P001600000160.084.0 - 88.584.0In
 Put
PCVX250417P001550000155.079.0 - 83.579.0In
 Put
PCVX250417P001500000150.074.0 - 78.574.0In
 Put
PCVX250417P001450000145.069.0 - 73.569.0In
 Put
PCVX250417P001400000140.064.0 - 68.564.0In
 Put
PCVX250417P001350000135.059.0 - 63.559.0In
 Put
PCVX250417P001300000130.054.0 - 58.554.0In
 Put
PCVX250417P001200001120.044.7 - 48.519.1In
 Put
PCVX250417P001150001115.039.5 - 43.729.9In
 Put
PCVX250417P001100002110.034.5 - 39.018.85In
 Put
PCVX250417P00105000302105.030.0 - 34.321.37In
 Put
PCVX250417P001000004100.025.6 - 30.019.0In
 Put
PCVX250417P00090000990.017.0 - 21.513.9In
 Put
PCVX250417P00085000185.013.3 - 16.94.24In
 Put
PCVX250417P0008000016480.010.1 - 14.515.06In
 Put
PCVX250417P0007500022575.07.2 - 11.48.75In
 Put
PCVX250417P0007000033370.05.0 - 8.98.56Out
 Put
PCVX250417P0006500061665.03.0 - 7.35.83Out
 Put
PCVX250417P000600002260.01.55 - 5.33.0Out
 Put
PCVX250417P00055000255.00.5 - 4.92.1Out
 Put
PCVX250417P00050000250.00.05 - 4.91.6Out
 Put
PCVX250417P00045000145.00.0 - 3.11.4Out

Vaxcyte Total Stockholder Equity

Total Stockholder Equity

3.47 Billion

At this time, Vaxcyte's Total Stockholder Equity is fairly stable compared to the past year.

Vaxcyte Corporate Management

Mikhail JDGeneral VPProfile
Karen AldereteEx HRProfile
Whitney JonesChief OfficerProfile
Ashish MBACoFounder OfficerProfile
Jeff FairmanCoFounder ResearchProfile
Mark MBAChief OfficerProfile

Additional Tools for Vaxcyte Stock Analysis

When running Vaxcyte's price analysis, check to measure Vaxcyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxcyte is operating at the current time. Most of Vaxcyte's value examination focuses on studying past and present price action to predict the probability of Vaxcyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxcyte's price. Additionally, you may evaluate how the addition of Vaxcyte to your portfolios can decrease your overall portfolio volatility.